Skip to main content
Premium Trial:

Request an Annual Quote

Structural Genomix in $11M Deal with Cystic Fibrosis Foundation

NEW YORK, Feb 8 - Structural Genomix said Thursday it reached an agreement with the Cystic Fibrosis Foundation to determine the structure of a protein, cystic fibrosis transmembrane regulator, which is involved in causing cystic fibrosis.

" CF scientists have attempted to determine the structure of the CFTR protein, but without a lot of success. The CF Foundation thinks that Structural Genomix will bring new cutting edge technologies to the problem, and hopefully accomplish this difficult task," Robert Beall, CEO of the Cystic Fibrosis Foundation, said in a statement.

Under the terms of the five-year deal, the Cystic Fibrosis Foundation will give $11 million to Structural Genomix in research funding and will pay additional milestone and royalty payments.

Structural Genomix, which employs x-ray crystallography to determine protein structures, will study sequence variations in the CFTR gene across species to determine the x-ray structure of the protein. A defective gene that codes for the CFTR protein causes the development of a thick mucus that damages airways and the digestive tract and leads to a host of infectious diseases.

The company said that no 3-D structure of CFTR currently exists.

Structural Genomix of San Diego and the Cystic Fibrosis Foundation hope that by understanding the structure of CFTR, drug makers will be able to develop new compounds and therapies for cystic fibrosis.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.